fda tirzepatide compounding warning 2024 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Compounded Tirzepatide: Legal & Safe

Key Takeaways A slew of new studies suggest that semglutide (Ozempic/Wegovy) has benefits for health that extend beyond weight loss Subset analyses of prior trials find the drug can curb deaths from all causes, ease COVID-19 severity and treat heart failure These benefits weren't always the result of weight loss, suggesting other mechanisms may be at work FRIDAY, Aug.30, 2024 (HealthDay News) -- New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways

Microsomal GST1 (MGST1) and GSTP1-1, which are frequently overexpressed in cancer cells, contribute to DOX resistance

But dehydration worsens nearly every side effect, from nausea to constipation to fatigue

Each batch of peptides is carefully sourced, verified through third-party testing, and documented for purity and potency